Estimating the Burden of Disease Managed by the Indonesian National Health Insurance System

A 10-Year Retrospective Analysis of 9.5 Million Advanced Referral Records (2015-2024)

Total Records

9.5M

Unique Patients

976k

Total DALYs Managed

129.2M

The Challenge: Defining System-Managed Burden

Traditional modeling assesses theory; this specific 1% sampling (PSTV15) measures exactly what crushes Universal Health Coverage capacity.

The Primary Care "Iceberg"

Primary care (FKTP) generates over 3 billion weighted visits across ten years. However, this immense volume is overwhelmingly dominated by symptomatic complaints (cough, fever, headache) and routine low-acuity infections (common cold, pharyngitis).

By exclusively focusing our DALY framework on the Advanced Referral Tier (FKRTL), we filter out vast amounts of administrative noise to isolate the severe morbidity and premature mortality actively draining systemic clinical capability.

  • 130M+ Primary visits for Acute URIs
  • 101M+ Primary visits for basic Hypertension

How System Burden Evolved Year by Year

The annual DALY trajectory exposes the COVID-19 disruption of 2020-2021 and a dramatic surge in 2023-2024, suggesting a complex interaction between pandemic backlogs and population aging. Notably, YLD has grown proportionally over time, indicating a survivorship effect — more patients are living longer with severe chronic conditions rather than dying rapidly.

YLL Dominated

In 2015, YLL contributed 84% of all DALYs — the hallmark of underprepared systems facing acute severe disease.

COVID Disruption

2020 saw an 18% drop in DALYs vs. 2019, while raw hospital visits fell 19.3%, reflecting a shift toward managing higher-acuity emergent cases during lockdowns.

YLD Rising

By 2024, YLD reached 51% of total DALYs (vs. 16% in 2015), reflecting a growing morbidity burden from chronic disease survivability.

NCD Surge: The Rising Tide of Chronic Disease at the Specialist Level

The top 5 specialist visitation categories reveal a stark transition. Cardiovascular diseases alone have grown from ~1.8M visits in 2015 to over 17.3M in 2024 — a 9.8-fold increase. This escalating volume of long-term chronic patients is the principal pressure point threatening the fiscal sustainability of the JKN advanced referral tier.

Utilization Landscape: What fills JKN specialist clinics?

Across the full 10-year span, administrative Health Status codes (Z-codes: wellness checks, follow-ups, dialysis sessions) account for the single largest block of visits — reflecting the high revisit burden imposed by chronic disease management. True disease categories (Cardiovascular, Musculoskeletal, Endocrine) occupy the subsequent ranks.

The CKD Anomaly: Extreme Resource Concentration

A staggering portion of specialist capacity is absorbed by a tiny fraction of the population. Looking at the Top 10 absolute highest utilizers in the national sample—individuals averaging ~200 hospital visits per year over a decade—Chronic Kidney Disease (ESRD) clearly dominates.

Top 10 Extreme Utilizers (2015-2024)

When tracking the longitudinal records of the most frequent visitors in the 1% sample, exactly half (5/10) are patients undergoing relentless, multi-year hemodialysis.

  • 7 of Top 10 are ESRD / CKD Patients
  • Averaging ~180-210 hospital visits/year
  • Indicates catastrophic failure in upstream prevention

Who Are the JKN FKRTL Patients?

The study cohort drawn from the BPJS FKRTL 1% national sample reveals a strongly socioeconomically stratified enrollment. Formal workers (PPU: Pekerja Penerima Upah) and government subsidy recipients (PBI: Penerima Bantuan Iuran) together make up the majority, with a notably higher female representation consistent with the usage of obstetric and maternal services.

By Gender
By Coverage Class
By Enrollment Segment

Top Drivers of Advanced System Health Loss

Stroke and Neoplasms represent massive drivers of both continuous morbidity (YLD) and immediate, premature in-hospital mortality (YLL). The extreme concentration of resources on Chronic Kidney Disease indicates a failure in upstream gatekeeping.

Morbidity vs. Mortality Ratio

System-Managed Burden by Sex (Top 15 Causes)

Sex-disaggregated DALYs reveal strikingly different risk profiles. Males carry a higher burden in trauma and cardiovascular conditions; females are disproportionately affected by oncological and endocrine disorders. Maternal Disorders, expectedly, are almost entirely female (97.4%).

Male-Dominant

Injuries (66% male) and Ischemic Heart Disease (60.7%) reflect higher male exposure to trauma, smoking, and cardiovascular risk.

Female-Dominant

Diabetes Mellitus (64.6% female) and Neoplasms (61.1%) show higher female burden, consistent with sex-specific malignancies and metabolic risk.

Notable Balance

Stroke (53% male / 47% female) and CKD (53.9% / 46.1%) illustrate near-equal burden — systemic chronic disease affects both sexes heavily.

Sensitivity Analysis: Local Demographic Realities

Applying the standard GBD theoretical maximum life expectancy (~86 years) profoundly inflates the Years of Life Lost (YLL) compared to utilizing the true Indonesian national life expectancy at birth (~71.3 years).

Future Outlook: The 2050 System Surge

Modeling the JKN’s current institutional growth rate (metastasizing latent demand) alongside UN population ageing forecasts suggests an 17.6-fold increase in managed DALYs by 2050. This "UHC Acceleration Paradox" reveals that institutional growth—finally treating the untreated—is a far more explosive driver of system pressure than demographics alone.

Institutional Surge

343.1M Managed DALYs: The projected clinical burden if the specialist tier continues to capture the "hidden" community burden at current rates.

GBD Baseline

36.1M DALYs: The burden if only population growth and ageing occurred, without further institutional expansion (Reference only).

The Gap

A ~9.5x delta between pure demographics and system capture, highlighting the massive "referral iceberg" JKN is currently navigating.